Human cytomegalovirus glycoproteins

Intervirology

Volumn 39, Issue 5-6, 1996, Pages 401-412

  Britt, William J ^a   Mach, Michael ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Human cytomegalovirus envelope; Human cytomegalovirus glycoproteins

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CELL FUSION; CELLULAR IMMUNITY; GLYCOPROTEIN SYNTHESIS; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENE; VIRUS IMMUNITY; VIRUS REPLICATION;

ANIMALS; CYTOMEGALOVIRUS; GLYCOPROTEINS; HUMANS; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

HERPES; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 0030426256     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150510     Document Type: Article

References (97)

1. Roizman B, Sears AB; Herpes simplex viruses and their replication; in Fields BN, Knipe DM, Howley PM, Chanock RM, Mclnick JL, Mo-nath TP, Roizman B, Straus SF, (eds): Virology, ed 3, Philadelphia, Lippincott-Raven, 1996.pp 2231-2295.
2. Johnson DC, Ligas MW: Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: Quantitative evidence for virus-specific cell surface receptors, J Virol 1988:62:4605-4612.
3. Forrester A, Farrell H, Wilkinson C, Kavc J, Davis PN, Minson T: Construction and properties of a mutant of herpes simplex virus type I with glycoprotein H coding sequences deleted, J Virol 1992:66:341-348.
4. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cernv R, Horsnell T, Hutchison CA, Kou-zarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169, Curr Top Microbiol Immunol 1990: 154:125-170.
5. Cha T, Tom E, Kembel GW, Duke CM, Mo-carski ES, Spaete RR: Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains, J Virol 1996:70: 78-83.
6. Britt WJ, Vugler L, Butfiloski EJ, Stephens F.B: Cell surface expression of human cytomegalovirus (HCMV) gp55-l 16 (gB): Use of HCMV-vaecinia recombinant virus infected cells in analysis of the human neutralizing antibody response, J Virol 1990:64:1079- 1085.
7. Rasmussen L, Morris S, Wolitz R, Dowling A, Fessell J, Holodniy M, Merigan TC: Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis, J Infect Dis 1994:170: 673-677.
8. Boppana SB, Britt WJ: Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection, J Infect Dis 1995:171:1115-1121.
9. Boppana SB, Polis MA, Kramer AA, Britt WJ, Koenig S: Virus specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infectcd individuals with HCMV retinitis, J Infect Dis 1995;171:182-185.
10. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Plocgh HL: The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol, Cell 1996:84:769-779.
11. Bzik DJ, Fox BA, DcLuca NA, Person S: Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virustype 1, Virology 1984:133:301-314.
12. Litwin V, Jackson W, Grose C: Receptor properties of two varicclla-z.oster virus glycoproteins, gpl and gplV, homologous to herpes simplex virus gE and gl, J Virol 1992:66:3643- 3651.
13. Schlciss MR: Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene, Virology 1994:202:173-185.
14. Rapp M, Messcrle M, Buhler B, Tannheimer M, Keil GM, Koszinowski UH: Identification of the murine cytomegalovirus glycoprotein B geneand its expression by recombinant vaccinia virus, J Virol 1992:66:4399-4406.
15. Chou S, Marousek GI: Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus, Virology 1992:191:523-528.
16. Emini F.A, Luka J, Armstrong ME, Keller PM, Ellis RW, Pearson GR: Identification of an F.pstein-Barr virus glycoprotein which is anti-genicallv homologous to the varicella-zoster virus glycoprotein 11 and the herpes simplex virus glycoprotein B, Virology 1987:157:552-555.
17. Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstem B, Ho-ness RW: Primary structure of the herpesvirus saimiri genome, J Virol 1992:66:5047-5058.
18. Mctlcnleiter TC: Molecular biology of pseudo-rabies (Aujcszky’s disease) virus, Comp Immunol Microbiol Infect Dis 1991:14:151.
19. Peetcrs B, de Wind N, Hooisma M, Wagcnaar F, Giclkens A, Moormann R: Pseudo-rabies virus envelope glycoproteins gp50 and gll are essential for virus penetration, but only gll is involved in membrane fusion, J Virol 1992:66: 894-905.
20. Hcrrold RE, Marchini A, Fruchling S, Long-neckcr R: Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo, J Virol 1996:70:2049-2054.
21. Kouzarides T, Bankier AT, Satchwell SC, Wcs-lon K, Tomlinson P, Barrell BG: Sequence and transcription analysis of the human cytomcga-lovirusDNA polvmerasc gene, J Virol 1987:61: 125-133.
22. Spaete RR, Thayer RM, Probcrt WS, Masiar, PR, Chamberlain SH, Rasmussen L, Mcrigan TC, Pachl C: Human cytomegalovirus strain Townc glycoprotein B is processed by proteolytic cleavage, Virology 1988:167:207-225.
23. Chou S: Comparative analysis of sequence variation in gp 116 and gp55 components of glycoprotein B of human cytomegalovirus, Virology 1992:188:388-390.
24. Rcschke M, Reis B, Noding K, Rohsicpe D, Richter A, Mockenhaupt T, Garten W, Radsak K: Constitutive expression of human cytomegalovirus glycoprotein B (pgUL55) with muta-genized carboxy-terminal hydrophobic domains, J Gen Virol 1995:76:113-122.
25. Britt WJ, Vugler LG: Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus, J Virol 1989:63:403- 410.
26. Britt WJ, Auger D: Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus, J Virol 1986:58:185-191.
27. Kari B, Liu YN, Gocrtz, R, Lusscnhop N, Stins-ki MF, Gehrz R: Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB), J Gen Virol 1990:71:2673-2680.
28. Vey M, Schafer W, Reis B, Ohuchi R, Britt W, Garten W, Klcnk HD, Radsak K: Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoproteasc furin, Virology 1995:206:746- 749.
29. Britt WJ: Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus, Virology 1984:135:369-378.
30. Greteh DR, Kari B, Rasmussen L, Gehrz RC, Stinski MF: Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus, J Virol 1988:62:875-881.
31. Britt WJ, Vugler LG: Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-l 16), J Virol 1992: 66:6747-6754.
32. Billstrom MA, Britt WJ: Postoligomerization folding of human cytomegalovirus glycoprotein B: Identification of folding intermediates and importance of disulfide bonding, J Virol 1995: 69:7015-7022.
33. Ohizumi Y, Suzuki H, Matsumoto Y, Masuho Y, Numazaki Y: Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55, J Gen Virol 1992:73:2705-2707.
34. Nowlin DM, Cooper NR, Compton T: Expression of a human cytomegalovirus receptor correlates with infectihility of cells, J Virol 1991: 65:3114-3121.
35. Kari B, Gehrz, R: Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-Il, J Gen Virol 1993:74:255-264.
36. Compton T, Nowlin DM, Cooper NR: initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate, Virology 1993:193:834-841.
37. Compton T: Towards a definition of the HCMV entry pathway, Scand J Infect Dis Suppl 1995:99:30-32.
38. Wright JF, Kurosky A, Wasi S: An endothelial cell-surfacc form of annexin II binds human cytomegalovirus, Biochem Biophvs Res Corn-mun 1994:198:983-989.
39. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L: Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies, Virology 1994: 201:263-276.
40. Tugizov S, Wang Y, Qadri I, Navarro D, Maid-ji E, Pereira L: Mutated forms of human cytomegalovirus glycoprotein B arc impaired in inducing syncytium formation, Virology 1995: 209:580-591.
41. Gage PJ, Levine M, Glorioso JC: Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B, J Virol 1993:67:2191-2201.
42. Alford CA, Hayes K, Britt WJ: Primary cytomegalovirus infection in pregnancy: Comparison of antibody responses to vims encoded proteins between women with and without intrauterine infection, J Infect Dis 1988:158:917- 924.
43. Urban M, Winkler T, Landini MP, Britt W, Mach M: Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus, J Infect Dis 1994:169:83-90.
44. Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, McVoy ML, Best AM: Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age, J Infect Dis 1995;171:26-32.
45. Liu YN, Klaus A, Kari B, Stinski MF, Edk-hardt J, Gehrz RC: The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cclI immune responses in humans, J Virol 1991:65: 1644-1648.
46. Marshall GS, Rabalais GP, Stout GO, Wal-devcr SL: Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity, J Infect Dis 1992:165:381-384.
47. Gonczol E, de Taisne C, Hirka G, Bercnsci K, Lin WC, Paoletti E, Plotkin S: High expression of human cytomegalovirus HCMVFgB protein in cells infected with a vaccinia-gB recombinant: The importance of the gB protein in HCMV immunity, Vaccine 1991:9:631-637.
48. Mevcr H, Sundqvist VA, Pereira L, Mach M: Glycoprotein gp 116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies, J Gen Virol 1992:73: 2375-2383.
49. Utz U, Britt WJ, Vugler LG, Mach M: Identification of a neutralizing epitope on the glycoprotein gp58 of human cytomegalovirus, J Virol 1989:63:1995-2001.
50. Wagner B, Kropff B, Kalbachcr H, Britt W, Sundqvist VA, Ostbcrg L, Mach M: A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus, J Virol 1992:66:5290-5297.
51. Bonci A, Bracci L, Caudai C, Lozzi L, Moschct-tini D, Niccolai N, Scarselli M, Valensin PE, Neri P: Characterization of immunoreactive octapcptidcs of human-cytomcgalovirus gp58, Eur J Biochem 1993:215:383-387.
52. Schoppcl K, Hahfurther E, Britt W, Ohlin M, Borrcbaeck CAK, Mach M: Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures, Virology 1996:216: 133-145.
53. Knciss N, Mach M, Fay J, Britt WJ: Distribution of linear antigenic sites on glycoprotein gp55of human cytomegalovirus, J Virol 1991; 65:138-146.
54. Kropff B, Landini MP, Mach M: An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus, J Med Virol 1993:39:187- 195.
55. Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrcbaeck CA: Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/ 116 (gB), as determined with human monoclonal antibodies, J Virol 1993:67:703-710.
56. Bcninga J, Kropff B, Mach M: Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response, J Gen Virol 1995:76:153-160.
57. Utz U, Koenig S, Coligan JE, Biddison WE: Presentation of three different viral peptides, HTLV-1 tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule, J Immunol 1992,149:214-221.
58. Roy DM, Grundy J, Emery VC: Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: Comparison of isolates from renal transplant recipients and AIDS patients, J Gen Virol 1993:74:2499-2505.
59. Meyer H, Masuho Y, Mach M: The gpl 16 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope, J Gen Virol 1990:71:2443-2450.
60. Qadri I, Navarro D, Paz P, Pereira L: Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus, J Gen Virol 1992;73:2913-2921.
61. Silvestri M, Sundqvist VA, Ruden U, Wahren B: Characterization of a major antigenic region on gp55 of human cytomegalovirus, J Gen Virol 1991:72:3017-3023.
62. Liu YN, Curtsinger J, Donahue PR, Klaus A, Opti/, G, Cooper J, Karr RW, Bach FH, Gchrz RC: Molecular analysis of the immune response to human cytomegalovirus glycoprotein B, I, Mapping of HLA-rcstricted helper T cell epitopes on gp9.3, J Gen Virol 1993:74:2207- 2214.
63. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenburg PD: Class 1 MHC-rcstricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression, J Immunol 1991:146:2795-2804.
64. Cranage MP, Smith GL, Bell SE, Hart II, Brown C, Bankier AT, Tomlinson P, Barrell BG, Minson TC: Identification and expression of human cytomegaloviruses (HCMV) glycoprotein H: Neutralization of HCMV infcctivity with anti-gH monoclonal antibody, J Virol 1988;62:1416-1422.
65. Pachl C, Probert WS, Hcrmscn KM, Masiarz PR, Rasmussen L, Merigan TC, Spaete RR: The human cytomegalovirus strain Townc glycoprotein H gene encodes glycoprotein p86, Virology 1989:169:418-426.
66. Keay S, Baldwin B: Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment, J Virol 1991:65:5124-5128.
67. Kaye JF, Gompels UA, Minson AC: Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV ULI15 gene product, J Gen Virol 1992:73:2693- 2698.
68. Spacte RR, Perot K, Scott PI, Nelson JA, Slins-ki MF, Pachl C: Coexpression of truncated human cytomegalovirus gH with the ULI 15 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface, Virology 1993:193:853- 861.
69. Bogner E, Reschke M, Reis B, Reis E, Britt W, Radsak K: Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus, Arch Virol 1992:126: 67-80.
70. Chou S: Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus, J Infect Dis 1992:166:604-607.
71. Rapp M, Lucin P, Mcsscrlc M, Loh LC, Koszi-nowski UH: Expression of the murine cytomegalovirus glycoprotein 11 by recombinant vaccinia virus, J Gen Virol 1994:75:183-188.
72. Urban M, Klein M, Britt WJ, Hassfurther E, Mach M: Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response, J Gen Virol 1996, in press.
73. Hutchinson L, Browne H, Wargent V, Davis-Poynter N, Primorac S, Goldsmith K, Minson A, Johnson DC: A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH, J Virol 1992:6:2240-2250.
74. Li Q, Turk SM, Hull-Fletchcr LM: The Ep-stcin-Barr virus (EBV) BZ1.F2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells, J Virol 1995:69: 3987-3994.
75. Keay S, Merigan TC, Rasmussen L: Identification of cell surface receptors for the 86-kilodal-ton glycoprotein of human cytomegalovirus, Proe Natl Acad Sci USA 1989:86:10100-10103.
76. Duus KM, Hatfield C, Grose C: Cell surface expression and fusion by the varicclla-zoster virus gI LgL glycoprotein complex: Analysis by laser scanning confocal microscopy, Virology 1995;210:429-440.
77. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC: Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans, J Infect Dis 1991; 164:835-842.
78. Simpson JA, Chow JC, Baker J, Avdalovi N, Yuan S, Au D, Co MS, Vasquez M, Britt W, Coelingh KL: Neutralizing monoclonal antibodies that distinguish three antigenic sites on the human cytomegalovirus glycoprotein H have conformationally-distinct binding sites, J Virol 1993;67:489-496.
79. Urban M, Britt W, Mach M: The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific, J Virol 1992:66:1303-1311.
80. Rasmussen LE, Nelson RM, Kclsall DC, Mcri-gan TC: Murine monoclonal antibody to a single protein neutralizes the infectivitv of human cytomegalovirus, Proc Natl Acad Sci USA 1984;81:876-880.
81. Li L, Coelingh KL, Britt WJ: Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H, J Virol 1995:69:6047-6053.
82. Beninga J, Kalbachcr H, Mach M: Analysis of T helper cell response to glycoprotein H (gpUL75) of human cytomegalovirus, Evidence for strain specific T cell determinants, J Infect Dis, in press.
83. Lehner R, Meyer H, Mach M: Identification and characterization of a human cytomegalovirus gene coding fora membrane protein that is conserved among human herpesviruses, J Virol 1989;63:3792-3800.
84. Baines JD, Roizman B: The UL10 gene of herpes simplex virus I encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells, J Virol 1993;67:1441-1452.
85. Kari B, Li W, Cooper J, Gocrtz R, Radckc B: The human cytomegalovirus ULI00 gene encodes the gC-ll glycoproteins recognized by group 2 monoclonal antibodies, J Gen Virol 1994.75:3081-3086.
86. Kari B, Gchrz R: A human cytomegalovirus glycoprotein complex designated gC-ll is a major heparin-binding component of the envelope, J Virol 1992:66:1761-1764.
87. Britt WJ, Auger D: Identification of a 65.000 dalton virion envelope of human cytomegalovirus, Virus Res 1985;4:31-36.
88. Weston K, Barrell BG: Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus, J Mol Biol 1986:192:177-208.
89. Grctch DR, Kari B, Gchrz RC, Stinski MF: A mult genc family encodes the human cytomegalovirus glycoprotein complex gcll (gp47-52 complex), J Virol 1988:62:1956-1962.
90. Jones TR, Muzithras VP: Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain ADI 69, J Virol 1991;65:2024-2036.
91. Gretch DR, Stinski MF: Transcription of the human cytomegalovirus glycoprotein gene family in the short unique component of the viral genome, Virology 1990:174:522-532.
92. Jones TR, Muzithras VP, Giuzman Y: Replacement mutagenesis of the human cytomegalovirus genome: USI0 and US11 gene products are nonessential, J Virol 1991:65:5860-5872.
93. Grctch DR, Bale JJ, Gchrz RC, Stinski MF: Expression of a human cytomegalovirus glycoprotein multigene family, Virus Genes 1991:5: 203-214.
94. Pereira L, Maidji E, Tugizov S, Jones T: Deletion mutants in human cytomegalovirus glycoprotein US9 are impaired in cell-cell transmission and in altering tight junctions of polarized human retinal pigment epithelial cells, Scand J Infect Dis 1995:99:82-87.
95. Chang CP, Vesole DH, Nelson J, Oldstone MB, Stinski MF: Identification and expression of a human cytomegalovirus early glycoprotein, J Virol 1989:63:3330-3337.
96. Schlciss MR, Degnin CR, Geballe AP: Translational control of human cytomegalovirus gp48 expression, J Virol 1991;65:6782-6789.
97. Geballe AP, Morris DR: Initiation codons within 5'-leaders of mRNAs as regulators of translation, Trends Biochcm Sci 1994:19:159-164.